NERV – minerva neurosciences, inc (US:NASDAQ)

News

Minerva Neurosciences (NERV) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock, up from $4.00.
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
Minerva Neurosciences files $200M mixed shelf registration [Seeking Alpha]
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates [Yahoo! Finance]
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com